BASEL, Switzerland, Jan. 26, 2004 (PRIMEZONE) --
Details of release, presentations and material Change in time for London event
February 4, 2004 07.00 CET (Central European time) Release will be e-mailed and posted on the Roche IR website. Presentation slides and the Annual Report 2003 will be posted on the Roche IR website http://ir.roche.com. 08.00 CET Conference call will commence with presentations by senior management followed by a Q&A session. Participants will be: Dr. Erich Hunziker, Chief Financial Officer, William M. Burns, Head of the Pharmaceuticals Division and Heino von Prondzynski, Head of the Diagnostics Division Dr. Karl Mahler, Head of Investor Relations Analysts are invited to dial in to the conference using the following dial-in numbers: +41 91 610 5600 (Europe and ROW) or +44 207 107 06 11 (UK) or +1 866 291 4166 (USA). Please dial into the conference call 10-15 minutes before the call is scheduled to start. You are also invited to download the presentation from the website. Alternatively you can follow the conference as a Live Audio Webcast through the Internet site http://ir.roche.com. A replay of the conference call will be available one hour after the conference call, for 48 hours. Access is by dialing: +41 91 612 4330 (Europe), +44 207 866 4300 (UK) and +1 412 858 1440 (USA) and enter the conference ID 446 followed by the # sign. A replay of the webcast will be available on demand at http://ir.roche.com.
London, February 4, 2004
Due to flight schedules and restrictive new security guidelines practiced by some airlines the schedule for our London event had to be amended slightly. The conference will start 15 minutes earlier and will now begin at
15.15 London GMT (Greenwich Mean Time) / 16.15 CET
General Presentation and Q & A session will be held by:
Dr. Franz B. Humer, Chief Executive Officer
Dr. Erich Hunziker, Chief Financial Officer
William M. Burns, Head of the Pharmaceuticals Division and
Heino von Prondzynski, Head of the Diagnostics Division
Following the general presentation will be four break-out sessions, held simultaneously, covering the topics Strategy & Finance, Pharmaceuticals, Diagnostics and Accounting. The break-out sessions will be recorded and placed on the web within 48 hours. For those who cannot attend in person, the presentation and Q&A session can be listened to via a telephone link (listen only mode, no live access to speakers). Please dial into the call 10-15 minutes before is scheduled to start. The Dial in numbers are:
+41 91 610 5600 (Europe and ROW) or +44 207 107 06 11 (UK) or +1 866 291 4166 (USA).
You are also invited to download the presentation from the website. In addition, a Live Audio Webcast of the conference call will be available on our website http://ir.roche.com. A replay of the conference call will be available one hour after the event, for 48 hours. Access is by dialing: +41 91 612 4330 (Europe), +44 207 866 4300 (UK) and +1 412 858 1440 (USA) and enter the Conference ID 511 followed by the # sign. A replay ofthe webcast will be available on demand at http://ir.roche.com.
New York, February 5, 2004
14.30 New York EST (Eastern Standard Time) / 20.30 CET
General Presentation and Q & A will be held by:
Dr. Franz B. Humer, Chief Executive Officer
Dr. Erich Hunziker, Chief Financial Officer
William M. Burns, Head of the Pharmaceuticals Division and
Heino von Prondzynski, Head of the Diagnostics Division
Following the general presentation will be four break-out sessions
(sessions will be repeated once) covering the topics Strategy &
Finance, Pharmaceuticals, Diagnostics and Accounting. The break-out
sessions will be recorded and placed on the web within 48 hours.
For those who cannot attend in person, the presentation and Q&A
session can be listened to via a telephone link (listen only mode, no
live access to speakers). Please dial into the call 10-15 minutes
before is scheduled to start. The Dial in numbers are:
+41 91 610 5600 (Europe and ROW) or
+44 207 107 06 11 (UK) or
+1 866 291 4166 (USA).
You are also invited to download the presentation from the website.
In addition, a Live Audio Webcast of the conference call will be
available on our website http://ir.roche.com.
A replay of the conference call will be available one hour after the
event, for 48 hours. Access
is by dialing: +41 91 612 4330 (Europe), +44 207 866 4300 (UK) and +1
412 858 1440 (USA)
and enter the Conference ID 585 followed by the # sign. A replay of
the webcast will be available
on demand at http://ir.roche.com